World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
42598
World Ranking
12454
National Ranking
6379

Overview

Patricia Troncoso is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on fields within Medicine and Biochemistry, Genetics and Molecular Biology, with subfields including Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, Radiology, Nuclear Medicine and Imaging, and Oncology.

The main topics of their work cover areas such as Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Cancer, Lipids, and Metabolism, Radiopharmaceutical Chemistry and Applications, Cancer-related gene regulation, Cancer Genomics and Diagnostics, and Cancer Immunotherapy and Biomarkers.

Patricia Troncoso has contributed to publications in various respected journals. Frequent publication venues include:

  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • European Urology

Among the recent papers associated with their research are:

  • Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer, 2020, Science Translational Medicine
  • The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development, 2020, Clinical Cancer Research
  • PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate Cancer, 2021, Molecular Cancer Therapeutics
  • Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment, 2021, Clinical Cancer Research
  • Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies, 2020, European Urology

Their frequent co-authors include:

  • Christopher J. Logothetis
  • Paul G. Corn
  • Brian F. Chapin
  • Ana M. Aparicio
  • Miao Zhang

Best Publications

  • The Immune Landscape of Cancer

    Vésteinn Thorsson;David L Gibbs;Scott D Brown;Denise Wolf

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder

    Jonathan I. Epstein;Mahul B. Amin;Victor R. Reuter;Fathollah K. Mostofi

  • Expression of the Protooncogene bcl-2 in the Prostate and Its Association with Emergence of Androgen-independent Prostate Cancer

    Timothy J. McDonnell;Patricia Troncoso;Shawn M. Brisbay;Christopher Logothetis

  • Pathogenic Germline Variants in 10,389 Adult Cancers

    Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

  • Steps toward mapping the human vasculature by phage display

    Wadih Arap;Mikhail G. Kolonin;Martin Trepel;Johanna Lahdenranta

  • Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study

    Sameek Roychowdhury;Matthew K. Iyer;Dan R. Robinson;Robert J. Lonigro

  • MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.

    David H.F. Teng;Rong Hu;Huai Lin;Thaylon Davis

  • CTLA-4 blockade increases IFNγ-producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients

    Chrysoula I. Liakou;Ashish Kamat;Derek Ng Tang;Hong Chen

  • A COMPARATIVE ANALYSIS OF SEXTANT AND AN EXTENDED 11-CORE MULTISITE DIRECTED BIOPSY STRATEGY

    R. Joseph Babaian;Ants Toi;Kazumi Kamoi;Patricia Troncoso

  • p53 Protein Accumulation and Gene Mutation in the Progression of Human Prostate Carcinoma

    Nora M. Navone;Patricia Troncoso;Louis L. Pisters;Tamra L. Goodrow

  • VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer

    Jianjun Gao;John F. Ward;Curtis A. Pettaway;Lewis Zhichang Shi

  • Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial.

    Bradley C. Carthon;Jedd D. Wolchok;Jianda Yuan;Ashish Kamat

  • Proposed morphologic classification of prostate cancer with neuroendocrine differentiation

    Jonathan I. Epstein;Mahul B. Amin;Himisha Beltran;Tamara L. Lotan

  • Effective combinatorial immunotherapy for castration-resistant prostate cancer.

    Xin Lu;James W. Horner;Erin Paul;Xiaoying Shang

  • Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma.

    Mahul B. Amin;Jae Y. Ro;T. El-Sharkawy;Kwang M. Lee

  • Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression

    Guocan Wang;Xin Lu;Prasenjit Dey;Pingna Deng

  • Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer

    Ana M. Aparicio;Andrea L. Harzstark;Paul G. Corn;Sijin Wen;Sijin Wen

  • Fingerprinting the circulating repertoire of antibodies from cancer patients

    Paul J. Mintz;Jeri Kim;Kim Anh Do;Xuemei Wang

Frequent Co-Authors

Christopher J. Logothetis
Christopher J. Logothetis The University of Texas MD Anderson Cancer Center
Louis L. Pisters
Louis L. Pisters The University of Texas MD Anderson Cancer Center
Curtis A. Pettaway
Curtis A. Pettaway The University of Texas MD Anderson Cancer Center
Xuemei Wang
Xuemei Wang The University of Texas MD Anderson Cancer Center
Kim Anh Do
Kim Anh Do The University of Texas MD Anderson Cancer Center
Deborah A. Kuban
Deborah A. Kuban The University of Texas MD Anderson Cancer Center
Alberto G. Ayala
Alberto G. Ayala Cornell University
Timothy J. McDonnell
Timothy J. McDonnell The University of Texas MD Anderson Cancer Center
Dennis A. Johnston
Dennis A. Johnston Baylor University
Andrew C. von Eschenbach
Andrew C. von Eschenbach United States Food and Drug Administration

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in Medicine opens doors to a variety of specialized roles, many of which can be accessed through flexible online study options. In recent years, demand for skilled healthcare professionals—especially nurses—has risen significantly, prompting the emergence of numerous accredited online programs.

Those interested in advanced clinical practice might consider nurse practitioner programs that prepare graduates for leadership and direct patient care positions. For prospective nurses, securing the right credential is important, and enrolling in the cheapest online nursing program can provide a cost-effective entry to the field.

Experienced RNs looking to expand career opportunities and earning potential may opt for one of the cheap rn to bsn online programs, completing a bachelor’s degree with minimal disruption to their professional life. For those aiming for academic, research, or high-level clinical roles, an online nursing doctorate can be an excellent option.

Each of these pathways offers accessible, affordable options to advance your healthcare career in the US without sacrificing quality or flexibility.

Best Scientists Citing Patricia Troncoso

Trending Scientists